Biosante Pharmaceuticals, Inc. (NASDAQ:BPAX)
|
1.76 -0.04 (-2.22%) 1:03EST Delayed |
|
|
|
- Compare BPAX with:
- View: Line | Candlestick
Company Profile
Biosante Pharmaceuticals, Inc.
111 Barclay Boulevard
Lincolnshire, IL 60069
United States - Map
Phone: (847) 478-0500
Fax: (847) 478-9152
Website: www.biosantepharma.com
State of incorporation: Delaware
CEO: Stephen M. Simes
Employees: 23
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Development stage biopharmaceutical company
A specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism.
Recent news for BPAX
-
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
GlobeNewswire - 6 hours ago
-
Biotech Stocks: BioSante rallies on study; drug stocks slip
MarketWatch - 21 hours ago
-
HEADLINE STOCKS-U.S. small/midcap stocks on the move on March 11
Reuters - 23 hours ago
-
BioSante cites positive GVAX study, shares rise
AP - Yesterday at 12:56PM (EST)
-
UPDATE - BioSante says leukemia vaccine shows promise in study
Reuters - Yesterday at 11:00AM (EST)
-
- Yesterday at 11:00AM (EST)
-
Biotech Stocks: BioSante rallies on study; drug stocks slip
MarketWatch - Yesterday at 10:46AM (EST)
-
HEADLINE STOCKS-U.S. small/midcap stocks on the move on March 11
Reuters - Yesterday at 10:44AM (EST)
-
BioSante soars on study; drug stocks slip
MarketWatch - Yesterday at 10:11AM (EST)
-
HEADLINE STOCKS-U.S. small/midcap stocks to watch on March 11
Reuters - Yesterday at 8:42AM (EST)